Clinical trial reportBlood advancesPublished
Teclistamab and daratumumab immune-based doublet therapy for relapsed/refractory multiple myeloma: the TRIMM-2 study
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Blood advances
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Recurrence; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Bispecific; Antibodies, Monoclonal; Treatment Outcome; Adult; Aged; Aged, 80 and over; Middle Aged; Female
- PubMed ID
- 42685673
- PubMed Central ID
- PMC13782887
- Open access
- Yes, open
- Added to directory
- Source checked